ATP1A1 and glioblastoma: Furthermore, in cells transfected with ATP1A1 siRNAs, RB treatment substantially alleviated intracellular Ca2+ levels (Figure 5G and Supplementary Figure S3E) and restored the invasiveness of GBM cells (Figure 5H and Supplementary Figure S3F).